Finally, since TMPRSS2 expression is controlled by androgens, which could explain the greater frequency of severe COVID-19 in males, it is possible that androgen receptor antagonists might reduce susceptibility to developing a serious COVID-19 infection (Stopsack et al., 2020). Here, TMPRSS2 is linked to COVID-19.